SlideShare a Scribd company logo
1 of 67
Approach to myopathyApproach to myopathy
 HereditaryHereditary
 acquiredacquired
historyhistory
 Onset ageOnset age
 distributiondistribution
 CourseCourse
 MyalgiaMyalgia
 CrampCramp
 ContractureContracture
 Dark urineDark urine
 Myotonia ,Stiffness /warming up phenomenaMyotonia ,Stiffness /warming up phenomena
 Aggravating: exercise /diet/temperature/drugAggravating: exercise /diet/temperature/drug
examexam
 Limb girdleLimb girdle
 ScapuloperonealScapuloperoneal
 DistalDistal
 Ocular or pharyngealOcular or pharyngeal
 Neck extensorNeck extensor
 Atrophy or hypertrophyAtrophy or hypertrophy
 Myotonia or paramyotoniaMyotonia or paramyotonia
Ptosis usually without opthalmoplegiaPtosis usually without opthalmoplegia
Myotonic dystrophyMyotonic dystrophy
Congenital myopathyCongenital myopathy
Ptosis with opthalmoplegiaPtosis with opthalmoplegia
Oculopharyngeal muscular dystrophyOculopharyngeal muscular dystrophy
Mitochondrial myopathyMitochondrial myopathy
WeaknessWeakness
 Constant fluctuationConstant fluctuation
 Longlife acquiredLonglife acquired MGMG
periodic Pperiodic P
 metabolicmetabolic
 ProgressiveProgressive staticstatic
 Dystrophy congenitalDystrophy congenital
 AgeAge
 DistributionDistribution
 InheritanceInheritance
Work upWork up
 Muscles enzymeMuscles enzyme
 R/o metabolic screenR/o metabolic screen
 EMG&NCS (myotonia ,fibrillation, R/oEMG&NCS (myotonia ,fibrillation, R/o
neuropathy)neuropathy)
 Muscle biopsy (dystrophy/ congenitalMuscle biopsy (dystrophy/ congenital
myopathy, stain for enzyme level)myopathy, stain for enzyme level)
 Genetic studyGenetic study
 Other :Other :
 Forearm exercise testForearm exercise test
 specific Enzymes levelspecific Enzymes level
When do you suspectWhen do you suspect??
Hereditary myopathyHereditary myopathy
 StructuralStructural
 functionalfunctional
classificationclassification
 DystrophyDystrophy
 Congenital myopathyCongenital myopathy
 Channelopathies & myotoniaChannelopathies & myotonia
 Metabolic (fatty acid/Metabolic (fatty acid/
glycogensis/mitochondrial)glycogensis/mitochondrial)
muscular dystrophymuscular dystrophy
 are inherited myopathy characterized byare inherited myopathy characterized by
progressive muscles weaknessprogressive muscles weakness
&degeneration &subsequent replacement&degeneration &subsequent replacement
by fibrous & fatty connective tissueby fibrous & fatty connective tissue
 Historically were categorized by their:Historically were categorized by their:
 Age onset /distribution of weakness&Age onset /distribution of weakness&
pattern of inheritancepattern of inheritance
 The genetic mutation &abnormal geneThe genetic mutation &abnormal gene
product were defined for many of themproduct were defined for many of them
MDMD
diseasedisease inheritanceinheritance ageage proteinprotein
duchenneduchenne X linkedX linked 2y2y dystrophindystrophin
beckersbeckers X linkedX linked 5-155-15 ....
Emery-dreifussEmery-dreifuss X linkedX linked childhchildh emerinemerin
LGDLGD AD/ARAD/AR sacroglycansacroglycan
Cong/CNSCong/CNS ARAR birthbirth
Cong/noCNSCong/noCNS ARAR .... merosinmerosin
Distal MDDistal MD AD/ARAD/AR
bethlenbethlen ADAD
FSHFSH ADAD Child&Child&
adultadult
oculodystrophyoculodystrophy ADAD 55thth
decdec
Myotonic type1Myotonic type1 ADAD 2th,3th2th,3th
decadedecade
Myotonic type 2Myotonic type 2 ADAD
myofibrillarmyofibrillar ADAD desmmindesmmin
Duchenne MDDuchenne MD
 Incidence: 1/3500 male birthIncidence: 1/3500 male birth
 1/3 new mutation1/3 new mutation
 c/p:as early as 2-3y with delayc/p:as early as 2-3y with delay
milestonesmilestones
 Progressive limb girdle patternProgressive limb girdle pattern
 Fall 5-6y/difficult climb stair 8y,Fall 5-6y/difficult climb stair 8y,
confined to wheelchair 12yconfined to wheelchair 12y
 Joint constructers 6-10yJoint constructers 6-10y
 Calf hypertrophy is earlyCalf hypertrophy is early
 Muscles atrophy lateMuscles atrophy late
 Progressive kyphscliosis due to ParaspinalProgressive kyphscliosis due to Paraspinal
muscles weaknessmuscles weakness
 Reflex: biceps/knee/lost by age 10yReflex: biceps/knee/lost by age 10y
 ankle preserved late in diseaseankle preserved late in disease
 Respiratory s/s after age 10Respiratory s/s after age 10
 Cardiac: generally asymptomaticCardiac: generally asymptomatic
 CHF, arrhythmia lateCHF, arrhythmia late
 90% abnormal ECG :tall rt R90% abnormal ECG :tall rt R
wave,deep left Q wavewave,deep left Q wave
 Echo: hypokinesia ,dilatation ofEcho: hypokinesia ,dilatation of
ventricular wallventricular wall
 GI: intestinal pseudo obstructionGI: intestinal pseudo obstruction
 IQ: one SD below NIQ: one SD below N
lablab
 A dystrophin gene deletion can be detected by:A dystrophin gene deletion can be detected by:
 DNA analyses from leukocytes by PCR in 2/3DNA analyses from leukocytes by PCR in 2/3
patient or DNA musclespatient or DNA muscles
 The other 1/3 DX by… muscles biopsy( dystrophinThe other 1/3 DX by… muscles biopsy( dystrophin
def by stain &WB ,typical features of MD)def by stain &WB ,typical features of MD)
 CK:20-100 XN ,decline laterCK:20-100 XN ,decline later
 EMG:myopathic &fibrillationEMG:myopathic &fibrillation
 Note :if DNA study +ve no need for EMGNote :if DNA study +ve no need for EMG
&muscles biopsy&muscles biopsy
Beckers MDBeckers MD
 Is milder formIs milder form
 5/100,0005/100,000
 Age :5-15yAge :5-15y
 Wheelchair at 30yWheelchair at 30y
 Cardiac similar to duchenneCardiac similar to duchenne
 Death by age 40Death by age 40
 Dx: DNA, muscle biopsy decrease inDx: DNA, muscle biopsy decrease in
dystrophindystrophin
 CK:moderatly elevatedCK:moderatly elevated
treatmenttreatment
 No treatment prevent theNo treatment prevent the
progressionprogression
corticosteroid :controlled trial withcorticosteroid :controlled trial with
predinsone 0,75mg/kg demonstratepredinsone 0,75mg/kg demonstrate
moderate improvement in strengthmoderate improvement in strength
&delay progression to wheel chair&&delay progression to wheel chair&
respiratory compromiserespiratory compromise
Emery-dreifussEmery-dreifuss
 X linkedX linked
 onset :childhoodonset :childhood
 Triad of:Triad of:
1-early contracture elbow, ankle1-early contracture elbow, ankle
&posterior cervical&posterior cervical
2-progressive scapulohumroperoneal2-progressive scapulohumroperoneal
3-cardiomyopathy with atrial conduction3-cardiomyopathy with atrial conduction
defectdefect
 CK :normal to or only moderateCK :normal to or only moderate
elevatedelevated
 The muscle biopsy :myopathicThe muscle biopsy :myopathic
&fewer dystrophic&fewer dystrophic
 DNA:mutation gene in Xq28 code forDNA:mutation gene in Xq28 code for
protien emerinprotien emerin
Limb girdle dystrophyLimb girdle dystrophy
 AR majorityAR majority
 Onset: adolescence or lateOnset: adolescence or late
childhood: sever child recessive muscularchildhood: sever child recessive muscular
dystrophydystrophy
 AR: defect in sacroglycan component ofAR: defect in sacroglycan component of
the DGC( sacroglycanopathythe DGC( sacroglycanopathy((
 Alpha sacrglycan adhelin is account forAlpha sacrglycan adhelin is account for
20%20%
 Onset:childhood& variableOnset:childhood& variable
 No intellectual impairment or cardiacNo intellectual impairment or cardiac
 Muscle biopsy :immune stain absent orMuscle biopsy :immune stain absent or
diminished for sacroglycandiminished for sacroglycan
 AD: onset: second and third decadesAD: onset: second and third decades
 Protein defect:caveolin-3Protein defect:caveolin-3
 There are multiple subtypesThere are multiple subtypes
 AD type 1:1A,1B …AD type 1:1A,1B …
 AR type 2:AR type 2:
Congenital muscular dystrophyCongenital muscular dystrophy
 ARAR
Perinatal onsetPerinatal onset
 c/p:hypotonia &proximalc/p:hypotonia &proximal
weakness,arthrogryposisweakness,arthrogryposis
 Two typesTwo types
 CNS involvement: severCNS involvement: sever mental retardationmental retardation
,visual, seizure ..cerebrocular dysplasia,,visual, seizure ..cerebrocular dysplasia,
progressive death by age 10-12progressive death by age 10-12
 No CNS :classic typeNo CNS :classic type MRI (hypomyelination),MRI (hypomyelination),
benign outcome, non progressivebenign outcome, non progressive
 Muscle biopsy :dystrophy…Muscle biopsy :dystrophy…
FSHFSH
 InheritanceInheritance: AD: AD
 Variable expression within the familiesVariable expression within the families
 AgeAge: childhood or adult life: childhood or adult life
 C/PC/P::
weakness early facial then descending to scapula stabilizerweakness early facial then descending to scapula stabilizer
muscles &muscles of the upper limb& distal weaknessmuscles &muscles of the upper limb& distal weakness
..peroneal ,the rate of progression to forearm &pelvic girdle..peroneal ,the rate of progression to forearm &pelvic girdle
 Asymmetrical/Asymmetrical/ deltoid preserved / joint contracture aredeltoid preserved / joint contracture are
uncommonuncommon
 Popeye handPopeye hand/ winging scapula// winging scapula/ no muscle hypertrophyno muscle hypertrophy
 Early onset worse prognosisEarly onset worse prognosis
 20% require wheelchair20% require wheelchair
Work upWork up
 CK:N or mild elevationCK:N or mild elevation
 Muscles biopsy: myopathicMuscles biopsy: myopathic
dystrophicdystrophic& occasionally prominent& occasionally prominent
mononuclear infiltratemononuclear infiltrate
 Gene: ch 4q35 gene deletionGene: ch 4q35 gene deletion
Myotonic dystrophyMyotonic dystrophy
 AD,AD, CTG repeatCTG repeat
 Affect :Affect :
skeletal,cardiac, smooth muscles, eye,endocrineskeletal,cardiac, smooth muscles, eye,endocrine
&brain&brain
 Onset :at any age ,usually at late 2Onset :at any age ,usually at late 2ndnd
decadedecade
 Some individual can be symptoms free theirSome individual can be symptoms free their
entire lifeentire life
 Sever form :congenital myotonic dystrophySever form :congenital myotonic dystrophy
 C/P:weakness:C/P:weakness:
(facial,temporalis wasting,ptosis,neck(facial,temporalis wasting,ptosis,neck
flexor,distal weakness progress toflexor,distal weakness progress to
involve limb girdle)involve limb girdle)
 Weakness >myotoniaWeakness >myotonia
 May be areflexicMay be areflexic
systemicsystemic
 Posterior sub scapular cataractPosterior sub scapular cataract
 Testicular atrophy& impotenceTesticular atrophy& impotence
 Intellectual impairmentIntellectual impairment
 Hypersomnia (central & obstructive)Hypersomnia (central & obstructive)
 Respiratory failureRespiratory failure
 Elevation of serum glu, rarely frank DMElevation of serum glu, rarely frank DM
 GI: dysphagea, pseudo obstructionGI: dysphagea, pseudo obstruction
 Cardiac conduction defect sudden deathCardiac conduction defect sudden death
 Fetal loss in femaleFetal loss in female
PROMMPROMM
 ADAD
 Proximal weakness, no distalProximal weakness, no distal
weaknessweakness
 Myotonia &myalgiaMyotonia &myalgia
 Less cardiac &other organLess cardiac &other organ
involvement except cataractinvolvement except cataract
Work upWork up
 CK:N or mild elevationCK:N or mild elevation
 EMG: myopathic &EMG: myopathic & myotoniamyotonia
 Muscle biopsy: atrophic, non specificMuscle biopsy: atrophic, non specific
 Gene :CTG repeat >50 in ch19q13.2Gene :CTG repeat >50 in ch19q13.2
tttttt
 Myotonia rarely sever to require tt:Myotonia rarely sever to require tt:
phenytoin is the only safe drugphenytoin is the only safe drug
 Annual ECG ..pacemaker mayAnnual ECG ..pacemaker may
requiredrequired
 Positive pressure ventilation supportPositive pressure ventilation support
 High risk in surgery (cardiacHigh risk in surgery (cardiac
&respiratory)&respiratory)
 Sedation & opiod use with cautionSedation & opiod use with caution
Distal dystrophyDistal dystrophy
 TypesTypes
 AD:4AD:4thth
&6&6thth
decadedecade
 AR:in early adult onset/late secondAR:in early adult onset/late second
or early 3or early 3rdrd
 CK :elevated 200xN ARCK :elevated 200xN AR
oculopharengealoculopharengeal
 ADAD
 Onset:5Onset:5thth
&6&6thth
decadedecade
 Ptosis &dysphagea later all extra ocularPtosis &dysphagea later all extra ocular
muscles &extremities affected (limb girdle)muscles &extremities affected (limb girdle)
but distal can be significant in somebut distal can be significant in some
variantvariant
 Slow progressive ,death from aspirationSlow progressive ,death from aspiration
pneumonia or starvationpneumonia or starvation
 Ck:n or mild elevatedCk:n or mild elevated
 Muscle biopsy :Muscle biopsy :rim vacuolesrim vacuoles
 Genetic GCG repeat in ch14Genetic GCG repeat in ch14
Congenital myopathyCongenital myopathy
 Are distinguished from dystrophy inAre distinguished from dystrophy in
threethree respect:respect:
 Characteristic morphologic alterationCharacteristic morphologic alteration
 At birthAt birth
 Non progressiveNon progressive
 However there are exception to allHowever there are exception to all
these generalizationthese generalization
 Inheritance: are variableInheritance: are variable
 c/p:c/p: hypotonia with subsequent developmental delayhypotonia with subsequent developmental delay
 Reduce muscles bulk, slender body build &long narrow faceReduce muscles bulk, slender body build &long narrow face
 Skeletal abnormalities: high arched palate ,pectusSkeletal abnormalities: high arched palate ,pectus
exacavitum, kyphscliosis, dislocated hip, pes cavusexacavitum, kyphscliosis, dislocated hip, pes cavus))
 Absent or reduced muscle stretch reflexAbsent or reduced muscle stretch reflex
 Weakness: limb girdle mostly, butWeakness: limb girdle mostly, but distaldistal weakness existweakness exist
 CK &EMG may be normalCK &EMG may be normal
 Muscle biopsy: the diagnostic methodMuscle biopsy: the diagnostic method
Central core myopathyCentral core myopathy
 Characterized by discrete zones ofCharacterized by discrete zones of
myofibrillar disruption in the centermyofibrillar disruption in the center
of muscles fiberof muscles fiber
 AD but can be sporadicAD but can be sporadic
 Mutation ch 19,similar to malignantMutation ch 19,similar to malignant
hyperthermia patienthyperthermia patient
 So anesthesia precaution areSo anesthesia precaution are
necessarynecessary
Nemaline myopathyNemaline myopathy
 Pathology: thePathology: the presence of rods orpresence of rods or
melamine bodies within muscles fibermelamine bodies within muscles fiber
 AD or ARAD or AR
 c/p:c/p:
 Sever neonatalSever neonatal form which is fatal in theform which is fatal in the
first year of lifefirst year of life
 Mild staticMild static
 Slowly progressiveSlowly progressive from birth or earlyfrom birth or early
childhoodchildhood
 Note :rods can present in HIV relatedNote :rods can present in HIV related
myopathy ,some inflammatorymyopathy ,some inflammatory
Centro nuclear (myotubularCentro nuclear (myotubular((
 Pathology: large central nuclei in thePathology: large central nuclei in the
muscle fibermuscle fiber
 X linked/AD/ARX linked/AD/AR
 sever neonatal/static or slowlysever neonatal/static or slowly
progressiveprogressive
 c/p: ptosis & opthalmoparesisc/p: ptosis & opthalmoparesis
 Genetic defect: mutation inGenetic defect: mutation in
myotubularin gene Xp28myotubularin gene Xp28
Metabolic myopathyMetabolic myopathy
Metabolic myopathyMetabolic myopathy
 Glucose/glycogen metabolismGlucose/glycogen metabolism
 Fattay acid metabolismFattay acid metabolism
 Purine nucleotidePurine nucleotide
 mitochondrialmitochondrial
Metabolic myopathyMetabolic myopathy
 Clues to hereditary metabolicClues to hereditary metabolic
myopathymyopathy
 Excersize induce weaknessExcersize induce weakness
&myoglobinuria…glycogen &lipid&myoglobinuria…glycogen &lipid
 Part of diffuse neurologicalPart of diffuse neurological
syndrome…mitochondrialsyndrome…mitochondrial
Glucose/glycogenGlucose/glycogen
 Glucose &its storage is essential for theGlucose &its storage is essential for the
short termshort term anaerobic energy (glycogensis)anaerobic energy (glycogensis)
 Two clinical presentation:Two clinical presentation:
 1-dynamic:type V/V11/V111/1X//XX11-dynamic:type V/V11/V111/1X//XX1
 2-static:fix weakness2-static:fix weakness
1/111/1V1/111/1V
 Inheritance:AR except forInheritance:AR except for
phosphoglycerate kinasephosphoglycerate kinase
Glycogensis with exerciseGlycogensis with exercise intoleranceintolerance
 C/P: exercise intolerance in the childhoodC/P: exercise intolerance in the childhood
followed by excertional induced muscle painfollowed by excertional induced muscle pain
&myoglobinurea in sec or 3&myoglobinurea in sec or 3rdrd
decade..decade..
 (Second wind phenomena)(Second wind phenomena)
 work up:work up:
CK/EMG normal between the attack in early stageCK/EMG normal between the attack in early stage
but after attack( myopathic &fibrillation)but after attack( myopathic &fibrillation)
 Forearm exercise testForearm exercise test
 Enzyme assayEnzyme assay
 Muscle biopsyMuscle biopsy
 Genetic for mutationGenetic for mutation
What is 0ther causes ofWhat is 0ther causes of
myoglobinureamyoglobinurea??
Glycogensis with fixed weaknessGlycogensis with fixed weakness
 Acid maltase deficiency:Acid maltase deficiency:
 Enzyme convert glycogen to glucoseEnzyme convert glycogen to glucose
 Three clinical variant:Three clinical variant:
 Infantile: pompes: progressiveInfantile: pompes: progressive
weakness ,enlargement of heart, tongueweakness ,enlargement of heart, tongue
&liver&liver death by age 2death by age 2
 Juvenile type: proximal weakness, mayJuvenile type: proximal weakness, may
calf hypertrophy death by age 20 fromcalf hypertrophy death by age 20 from
respiratory failurerespiratory failure
 Adult type:2&7Adult type:2&7thth
progressive limb girdle orprogressive limb girdle or
scapuloperoneal .no liver ,no heartscapuloperoneal .no liver ,no heart
involvementinvolvement
Work upWork up
 CK :moderately increasedCK :moderately increased
 EMG: myopathic changes &EMG: myopathic changes &myotonicmyotonic
discharge in paraspinusdischarge in paraspinus
 Enzyme assay:Enzyme assay:
 Muscle biopsy: a vacuolar myopathyMuscle biopsy: a vacuolar myopathy
with high glycogen contentwith high glycogen content
 Genetic: mutation in ch 17Genetic: mutation in ch 17
Fatty acid metabolismFatty acid metabolism
 Lipids are essential for aerobicLipids are essential for aerobic
metabolismmetabolism
 Dynamic & staticDynamic & static
 CPT:carnitine palmitoyl transeferaseCPT:carnitine palmitoyl transeferase
deficiencydeficiency
 Carnitine deficiencyCarnitine deficiency
CPTCPT
 Type 1:infancy &child hood with hepaticType 1:infancy &child hood with hepatic
dysfunctiondysfunction
 Type 2:exertional myalgia &myoglobinurea,Type 2:exertional myalgia &myoglobinurea,
it is the most frequently definableit is the most frequently definable
metabolic defect presenting with myoglobinureametabolic defect presenting with myoglobinurea
 AR ,gene 1p32AR ,gene 1p32
 The attacks occur after prolonged exercise,The attacks occur after prolonged exercise,
fasting, febrile illnessfasting, febrile illness
 Unlike mecardle disease the patient can tolerateUnlike mecardle disease the patient can tolerate
brief exercise ,no second wind phenomenabrief exercise ,no second wind phenomena
 Muscle strength are normal at restMuscle strength are normal at rest
lablab
 CK:n at restCK:n at rest
 Forearm exercise test :NForearm exercise test :N
 EMG: n at rest ,&myopathic during theEMG: n at rest ,&myopathic during the
attackattack
 Muscle biopsy: usually N ,except ofMuscle biopsy: usually N ,except of
myopathic changes after rhabdomylsismyopathic changes after rhabdomylsis
 Enzyme assayEnzyme assay
 ttt &meal frequency: increase CHO intakettt &meal frequency: increase CHO intake
&education about fasting &exercise&education about fasting &exercise
MitochondrialMitochondrial
 Kearns-sayer:Kearns-sayer: opthalmoplegia, retinitis pigmentosa, heartopthalmoplegia, retinitis pigmentosa, heart
block, hearing loss, short stature, ataxia, delayed 2block, hearing loss, short stature, ataxia, delayed 2ndnd
sexualsexual
characteristic, PN, respiratorycharacteristic, PN, respiratory
 MERFMERF: myoclonic epilepsy, generalized seizure, ataxia,: myoclonic epilepsy, generalized seizure, ataxia,
dementia, hearing loss, optic atrophy ,PN, cardiomyopathydementia, hearing loss, optic atrophy ,PN, cardiomyopathy
&cutenous lipoma&cutenous lipoma
 MNGLEMNGLE: mitochondrial neurogastrointestinal: mitochondrial neurogastrointestinal
encephalomyopathyencephalomyopathy
 POLIPPOLIP
::polyneuropathy,opthalmoplasia,leukoencephalopathy&polyneuropathy,opthalmoplasia,leukoencephalopathy&
intestinal pseudo obstructionintestinal pseudo obstruction
channelopathychannelopathy
 Non dystrophic myotoniaNon dystrophic myotonia
 Periodic paralysisPeriodic paralysis
 It due to mutation in differentIt due to mutation in different
channels gene leading to :channels gene leading to :
 Hyper excitability :myotoniaHyper excitability :myotonia
 In excitability: paralysisIn excitability: paralysis
Chloride channelopathyChloride channelopathy
 Mutation in CLMutation in CL
channel..hyperexcitability afterchannel..hyperexcitability after
depolarizationdepolarization
 Myotonia congenita:Myotonia congenita:
 AD..thomsen /AR:beckerAD..thomsen /AR:becker
 C/P:C/P:
muscle hypertrophy,muscle hypertrophy,
myotonia/becker type has fluctuatingmyotonia/becker type has fluctuating
limb girdle weaknesslimb girdle weakness
Sodium channleopathySodium channleopathy
 ADAD
 Onset: first decadeOnset: first decade
 Phenotypic types:Phenotypic types:
 Paramyotonia congenitaParamyotonia congenita
 Hyperkalemic periodic paralysisHyperkalemic periodic paralysis
 myotonia :Potassium sensitive disorder :myotonia :Potassium sensitive disorder :
myotonia fluctuantmyotonia fluctuant
myotonia permanentmyotonia permanent
acetazolamide responsive myotoniaacetazolamide responsive myotonia
Calcium channelopathyCalcium channelopathy
 HypokalemicHypokalemic
 malignant hyperthermiamalignant hyperthermia
C/P of channelopathyC/P of channelopathy
Paramytonia congenitaParamytonia congenita
 ADAD
 Onset :1Onset :1stst
decadedecade
 Paradoxical myotonia (Aggravated byParadoxical myotonia (Aggravated by
warm as well cold)warm as well cold)
 Face ,neck,forearmFace ,neck,forearm
 After several attempt of eye closure theAfter several attempt of eye closure the
patient can not open the eyepatient can not open the eye
 ttt: Na channels blocker mexiletinettt: Na channels blocker mexiletine
Hyperkalamic periodic paralysisHyperkalamic periodic paralysis
 K sensitive periodic paralysisK sensitive periodic paralysis
 Onset :1Onset :1stst
decadedecade
 Attack last:1-2 hAttack last:1-2 h
 During attack: areflexic with no ocular orDuring attack: areflexic with no ocular or
respiratory muscles weaknessrespiratory muscles weakness
 Strength is n between the attack, but someStrength is n between the attack, but some
patient has interictal limb girdle weaknesspatient has interictal limb girdle weakness
 Some families have myotonia &paramyotoniaSome families have myotonia &paramyotonia
 Aggravated: fasting/cold, shortly after exercise, KAggravated: fasting/cold, shortly after exercise, K
load, early AMload, early AM
 Episodes are rarely serous enough toEpisodes are rarely serous enough to
require acute tttrequire acute ttt
 ttt:ttt:
 oral CHOoral CHO
 Prevention: thiazide,B agonist, lowPrevention: thiazide,B agonist, low
K,high CHOK,high CHO
 Avoid fasting, strenuous exercise/Avoid fasting, strenuous exercise/
myotoniamyotonia
 No weaknessNo weakness
 Aggravated by K diet/ excretionAggravated by K diet/ excretion
 Can response to acetazolamideCan response to acetazolamide
hypokalemiahypokalemia
 AD:AD:
 It is the most frequent form of periodicIt is the most frequent form of periodic
paralysisparalysis
 Common in maleCommon in male
 Age: adolescenceAge: adolescence
 The attacks 3-24h/vague prodorme ofThe attacks 3-24h/vague prodorme of
stiffness &heaviness& rarely ocular,stiffness &heaviness& rarely ocular,
bulbar, respiratory involvedbulbar, respiratory involved
 Early Myotonia of eyelid & late interictalEarly Myotonia of eyelid & late interictal
proximal weaknessproximal weakness
 AggravatedAggravated: CHO meal, cold,hrs post: CHO meal, cold,hrs post
exercise, sleepexercise, sleep
 Work up:K level q 30min /TFT/Work up:K level q 30min /TFT/
 R/O 2R/O 2ndnd
causes of hypokalemiacauses of hypokalemia
 Tttt:Tttt:
 Acute:Acute: oral K Q30min ,if symptoms severoral K Q30min ,if symptoms sever
iv Kiv K
 Prevention:Prevention:
 Low CHO, low sodium dietLow CHO, low sodium diet
,spirnolactone, trimetrine,spirnolactone, trimetrine
32583 myopathy heridatery

More Related Content

What's hot

Qavi ppt epileptic syndromes of neonate and infancy (2)
Qavi ppt epileptic syndromes of neonate and infancy (2)Qavi ppt epileptic syndromes of neonate and infancy (2)
Qavi ppt epileptic syndromes of neonate and infancy (2)
qavi786
 
Approach to peripheral neuropathy
Approach to peripheral neuropathyApproach to peripheral neuropathy
Approach to peripheral neuropathy
NeurologyKota
 
Neurologic manifestations of alcoholism By Adetunji T.A.
Neurologic manifestations of alcoholism  By Adetunji T.A.Neurologic manifestations of alcoholism  By Adetunji T.A.
Neurologic manifestations of alcoholism By Adetunji T.A.
Adetunji Adesegun
 
Management of epilepsy in children
Management of epilepsy in childrenManagement of epilepsy in children
Management of epilepsy in children
PS Deb
 

What's hot (20)

Continuous Video EEG Monitoring
Continuous Video EEG MonitoringContinuous Video EEG Monitoring
Continuous Video EEG Monitoring
 
Periodic paralysis
Periodic paralysisPeriodic paralysis
Periodic paralysis
 
1st seizure ppt
1st seizure ppt1st seizure ppt
1st seizure ppt
 
status epilepticus presentation
status epilepticus presentation status epilepticus presentation
status epilepticus presentation
 
Qavi ppt epileptic syndromes of neonate and infancy (2)
Qavi ppt epileptic syndromes of neonate and infancy (2)Qavi ppt epileptic syndromes of neonate and infancy (2)
Qavi ppt epileptic syndromes of neonate and infancy (2)
 
Electrodiagnosis of GBS
Electrodiagnosis of GBSElectrodiagnosis of GBS
Electrodiagnosis of GBS
 
Eeg in encephalopathy
Eeg in encephalopathyEeg in encephalopathy
Eeg in encephalopathy
 
Non convulsive status epilepticus clinical features, diagnosis
Non convulsive status epilepticus clinical features, diagnosisNon convulsive status epilepticus clinical features, diagnosis
Non convulsive status epilepticus clinical features, diagnosis
 
Relative Contraindications for Thrombolysis in Acute Ischemic Stroke
Relative Contraindications for Thrombolysis in Acute Ischemic StrokeRelative Contraindications for Thrombolysis in Acute Ischemic Stroke
Relative Contraindications for Thrombolysis in Acute Ischemic Stroke
 
Approach to peripheral neuropathy
Approach to peripheral neuropathyApproach to peripheral neuropathy
Approach to peripheral neuropathy
 
GBS Acute Polyneuropathies (GBS)
GBS Acute Polyneuropathies (GBS)GBS Acute Polyneuropathies (GBS)
GBS Acute Polyneuropathies (GBS)
 
Approach to Milestone Regression
Approach to Milestone RegressionApproach to Milestone Regression
Approach to Milestone Regression
 
Neurologic manifestations of alcoholism By Adetunji T.A.
Neurologic manifestations of alcoholism  By Adetunji T.A.Neurologic manifestations of alcoholism  By Adetunji T.A.
Neurologic manifestations of alcoholism By Adetunji T.A.
 
Management of epilepsy in children
Management of epilepsy in childrenManagement of epilepsy in children
Management of epilepsy in children
 
Multiple sclerosis
Multiple sclerosisMultiple sclerosis
Multiple sclerosis
 
Lower motor disorders
Lower motor disordersLower motor disorders
Lower motor disorders
 
Infantile spasm and hypsarrythmia
Infantile spasm and hypsarrythmiaInfantile spasm and hypsarrythmia
Infantile spasm and hypsarrythmia
 
Neuropathies & myopathies - an overview
Neuropathies &  myopathies - an overviewNeuropathies &  myopathies - an overview
Neuropathies & myopathies - an overview
 
Approach to myopathy
Approach to myopathyApproach to myopathy
Approach to myopathy
 
Approach to neuroregression
Approach to neuroregressionApproach to neuroregression
Approach to neuroregression
 

Viewers also liked

Viewers also liked (6)

Approach to the_patient_with_myopathy
Approach to the_patient_with_myopathyApproach to the_patient_with_myopathy
Approach to the_patient_with_myopathy
 
4 Steps simple approach myopathy
4 Steps simple approach myopathy4 Steps simple approach myopathy
4 Steps simple approach myopathy
 
Myopathy
MyopathyMyopathy
Myopathy
 
Myopathies
MyopathiesMyopathies
Myopathies
 
Myopathies
MyopathiesMyopathies
Myopathies
 
MitoAction Mitochondrial Myopathy
MitoAction Mitochondrial MyopathyMitoAction Mitochondrial Myopathy
MitoAction Mitochondrial Myopathy
 

Similar to 32583 myopathy heridatery

Hemiplegia stroke
Hemiplegia strokeHemiplegia stroke
Hemiplegia stroke
thekumar
 
Sudden cardiac-death-1215093819502124-8
Sudden cardiac-death-1215093819502124-8Sudden cardiac-death-1215093819502124-8
Sudden cardiac-death-1215093819502124-8
Dr Khalid Hasan Khan
 
Chromosomal aberrations,downs syndrome-Dr.Gourav
Chromosomal aberrations,downs syndrome-Dr.GouravChromosomal aberrations,downs syndrome-Dr.Gourav
Chromosomal aberrations,downs syndrome-Dr.Gourav
Gourav Thakre
 
motor neuron disease.pptx
motor neuron disease.pptxmotor neuron disease.pptx
motor neuron disease.pptx
asdgja
 

Similar to 32583 myopathy heridatery (20)

Hemiplegia stroke
Hemiplegia strokeHemiplegia stroke
Hemiplegia stroke
 
Myopathy for medical students
Myopathy for medical studentsMyopathy for medical students
Myopathy for medical students
 
Sudden cardiac-death-1215093819502124-8
Sudden cardiac-death-1215093819502124-8Sudden cardiac-death-1215093819502124-8
Sudden cardiac-death-1215093819502124-8
 
musculardystrophies--2.ppt
musculardystrophies--2.pptmusculardystrophies--2.ppt
musculardystrophies--2.ppt
 
Paediatric oncology
Paediatric oncologyPaediatric oncology
Paediatric oncology
 
Inherited disorders of skeletal muscle
Inherited disorders of skeletal muscleInherited disorders of skeletal muscle
Inherited disorders of skeletal muscle
 
Evaluation and management of epilpesy
Evaluation and management of epilpesyEvaluation and management of epilpesy
Evaluation and management of epilpesy
 
Immune thrombocytopenia - anti-HLA antibodies pregnancy induced
Immune thrombocytopenia - anti-HLA antibodies pregnancy inducedImmune thrombocytopenia - anti-HLA antibodies pregnancy induced
Immune thrombocytopenia - anti-HLA antibodies pregnancy induced
 
Sensory Disturbance Feb 2016
Sensory Disturbance Feb 2016Sensory Disturbance Feb 2016
Sensory Disturbance Feb 2016
 
Muscular dystrophies
Muscular dystrophiesMuscular dystrophies
Muscular dystrophies
 
BASICS OF MRI
BASICS OF MRIBASICS OF MRI
BASICS OF MRI
 
(DMD)Duchenne muscular dystrophy-dr mohamed abunada
(DMD)Duchenne muscular dystrophy-dr mohamed abunada(DMD)Duchenne muscular dystrophy-dr mohamed abunada
(DMD)Duchenne muscular dystrophy-dr mohamed abunada
 
Down syndrome.pdf
Down syndrome.pdfDown syndrome.pdf
Down syndrome.pdf
 
Dementia
Dementia Dementia
Dementia
 
chromosomal anomalies.pptx
chromosomal anomalies.pptxchromosomal anomalies.pptx
chromosomal anomalies.pptx
 
Chromosomal aberrations,downs syndrome-Dr.Gourav
Chromosomal aberrations,downs syndrome-Dr.GouravChromosomal aberrations,downs syndrome-Dr.Gourav
Chromosomal aberrations,downs syndrome-Dr.Gourav
 
Muscular dystrophies
Muscular dystrophiesMuscular dystrophies
Muscular dystrophies
 
Muscular dystrophy. an overview
Muscular dystrophy. an overviewMuscular dystrophy. an overview
Muscular dystrophy. an overview
 
motor neuron disease.pptx
motor neuron disease.pptxmotor neuron disease.pptx
motor neuron disease.pptx
 
Muscle Diseases.lect.undergrad..pptx
Muscle Diseases.lect.undergrad..pptxMuscle Diseases.lect.undergrad..pptx
Muscle Diseases.lect.undergrad..pptx
 

More from Dr Ramesh Krishnan

More from Dr Ramesh Krishnan (20)

Diagnosis and management of Hyperkalemia
 Diagnosis and management of Hyperkalemia Diagnosis and management of Hyperkalemia
Diagnosis and management of Hyperkalemia
 
Abg ramesh
Abg rameshAbg ramesh
Abg ramesh
 
Ischemic heart disease
Ischemic heart disease Ischemic heart disease
Ischemic heart disease
 
Approach to management of Hyperkalemia
Approach to management of  HyperkalemiaApproach to management of  Hyperkalemia
Approach to management of Hyperkalemia
 
Anemia in ckd
Anemia in ckd Anemia in ckd
Anemia in ckd
 
Uti
UtiUti
Uti
 
Chronopharmacology
ChronopharmacologyChronopharmacology
Chronopharmacology
 
Betaadrenergicblockers 150412052808-conversion-gate01
Betaadrenergicblockers 150412052808-conversion-gate01Betaadrenergicblockers 150412052808-conversion-gate01
Betaadrenergicblockers 150412052808-conversion-gate01
 
Alphablockers 140105052831-phpapp02
Alphablockers 140105052831-phpapp02Alphablockers 140105052831-phpapp02
Alphablockers 140105052831-phpapp02
 
Anticholinergics drugs-Dr Ramesh Krishnan
Anticholinergics drugs-Dr Ramesh KrishnanAnticholinergics drugs-Dr Ramesh Krishnan
Anticholinergics drugs-Dr Ramesh Krishnan
 
6966901
69669016966901
6966901
 
Cholinergic ramesh
Cholinergic rameshCholinergic ramesh
Cholinergic ramesh
 
Myocardial infarction
Myocardial infarctionMyocardial infarction
Myocardial infarction
 
Pophyria
PophyriaPophyria
Pophyria
 
Porphyria r
Porphyria rPorphyria r
Porphyria r
 
Porphyria
PorphyriaPorphyria
Porphyria
 
Porphyria r (1)
Porphyria r (1)Porphyria r (1)
Porphyria r (1)
 
Shelly hyperlipidemia
Shelly hyperlipidemiaShelly hyperlipidemia
Shelly hyperlipidemia
 
Cvs 6
Cvs 6Cvs 6
Cvs 6
 
Fri t13 carl_fratter_3.15
Fri t13 carl_fratter_3.15Fri t13 carl_fratter_3.15
Fri t13 carl_fratter_3.15
 

32583 myopathy heridatery

  • 1.
  • 2.
  • 3. Approach to myopathyApproach to myopathy  HereditaryHereditary  acquiredacquired
  • 4. historyhistory  Onset ageOnset age  distributiondistribution  CourseCourse  MyalgiaMyalgia  CrampCramp  ContractureContracture  Dark urineDark urine  Myotonia ,Stiffness /warming up phenomenaMyotonia ,Stiffness /warming up phenomena  Aggravating: exercise /diet/temperature/drugAggravating: exercise /diet/temperature/drug
  • 5. examexam  Limb girdleLimb girdle  ScapuloperonealScapuloperoneal  DistalDistal  Ocular or pharyngealOcular or pharyngeal  Neck extensorNeck extensor  Atrophy or hypertrophyAtrophy or hypertrophy  Myotonia or paramyotoniaMyotonia or paramyotonia
  • 6. Ptosis usually without opthalmoplegiaPtosis usually without opthalmoplegia Myotonic dystrophyMyotonic dystrophy Congenital myopathyCongenital myopathy Ptosis with opthalmoplegiaPtosis with opthalmoplegia Oculopharyngeal muscular dystrophyOculopharyngeal muscular dystrophy Mitochondrial myopathyMitochondrial myopathy
  • 7. WeaknessWeakness  Constant fluctuationConstant fluctuation  Longlife acquiredLonglife acquired MGMG periodic Pperiodic P  metabolicmetabolic  ProgressiveProgressive staticstatic  Dystrophy congenitalDystrophy congenital
  • 9. Work upWork up  Muscles enzymeMuscles enzyme  R/o metabolic screenR/o metabolic screen  EMG&NCS (myotonia ,fibrillation, R/oEMG&NCS (myotonia ,fibrillation, R/o neuropathy)neuropathy)  Muscle biopsy (dystrophy/ congenitalMuscle biopsy (dystrophy/ congenital myopathy, stain for enzyme level)myopathy, stain for enzyme level)  Genetic studyGenetic study  Other :Other :  Forearm exercise testForearm exercise test  specific Enzymes levelspecific Enzymes level
  • 10. When do you suspectWhen do you suspect??
  • 13. classificationclassification  DystrophyDystrophy  Congenital myopathyCongenital myopathy  Channelopathies & myotoniaChannelopathies & myotonia  Metabolic (fatty acid/Metabolic (fatty acid/ glycogensis/mitochondrial)glycogensis/mitochondrial)
  • 14. muscular dystrophymuscular dystrophy  are inherited myopathy characterized byare inherited myopathy characterized by progressive muscles weaknessprogressive muscles weakness &degeneration &subsequent replacement&degeneration &subsequent replacement by fibrous & fatty connective tissueby fibrous & fatty connective tissue  Historically were categorized by their:Historically were categorized by their:  Age onset /distribution of weakness&Age onset /distribution of weakness& pattern of inheritancepattern of inheritance  The genetic mutation &abnormal geneThe genetic mutation &abnormal gene product were defined for many of themproduct were defined for many of them
  • 15. MDMD diseasedisease inheritanceinheritance ageage proteinprotein duchenneduchenne X linkedX linked 2y2y dystrophindystrophin beckersbeckers X linkedX linked 5-155-15 .... Emery-dreifussEmery-dreifuss X linkedX linked childhchildh emerinemerin LGDLGD AD/ARAD/AR sacroglycansacroglycan Cong/CNSCong/CNS ARAR birthbirth Cong/noCNSCong/noCNS ARAR .... merosinmerosin Distal MDDistal MD AD/ARAD/AR bethlenbethlen ADAD FSHFSH ADAD Child&Child& adultadult oculodystrophyoculodystrophy ADAD 55thth decdec Myotonic type1Myotonic type1 ADAD 2th,3th2th,3th decadedecade Myotonic type 2Myotonic type 2 ADAD myofibrillarmyofibrillar ADAD desmmindesmmin
  • 16. Duchenne MDDuchenne MD  Incidence: 1/3500 male birthIncidence: 1/3500 male birth  1/3 new mutation1/3 new mutation  c/p:as early as 2-3y with delayc/p:as early as 2-3y with delay milestonesmilestones  Progressive limb girdle patternProgressive limb girdle pattern  Fall 5-6y/difficult climb stair 8y,Fall 5-6y/difficult climb stair 8y, confined to wheelchair 12yconfined to wheelchair 12y
  • 17.  Joint constructers 6-10yJoint constructers 6-10y  Calf hypertrophy is earlyCalf hypertrophy is early  Muscles atrophy lateMuscles atrophy late  Progressive kyphscliosis due to ParaspinalProgressive kyphscliosis due to Paraspinal muscles weaknessmuscles weakness  Reflex: biceps/knee/lost by age 10yReflex: biceps/knee/lost by age 10y  ankle preserved late in diseaseankle preserved late in disease  Respiratory s/s after age 10Respiratory s/s after age 10
  • 18.  Cardiac: generally asymptomaticCardiac: generally asymptomatic  CHF, arrhythmia lateCHF, arrhythmia late  90% abnormal ECG :tall rt R90% abnormal ECG :tall rt R wave,deep left Q wavewave,deep left Q wave  Echo: hypokinesia ,dilatation ofEcho: hypokinesia ,dilatation of ventricular wallventricular wall  GI: intestinal pseudo obstructionGI: intestinal pseudo obstruction  IQ: one SD below NIQ: one SD below N
  • 19. lablab  A dystrophin gene deletion can be detected by:A dystrophin gene deletion can be detected by:  DNA analyses from leukocytes by PCR in 2/3DNA analyses from leukocytes by PCR in 2/3 patient or DNA musclespatient or DNA muscles  The other 1/3 DX by… muscles biopsy( dystrophinThe other 1/3 DX by… muscles biopsy( dystrophin def by stain &WB ,typical features of MD)def by stain &WB ,typical features of MD)  CK:20-100 XN ,decline laterCK:20-100 XN ,decline later  EMG:myopathic &fibrillationEMG:myopathic &fibrillation  Note :if DNA study +ve no need for EMGNote :if DNA study +ve no need for EMG &muscles biopsy&muscles biopsy
  • 20. Beckers MDBeckers MD  Is milder formIs milder form  5/100,0005/100,000  Age :5-15yAge :5-15y  Wheelchair at 30yWheelchair at 30y  Cardiac similar to duchenneCardiac similar to duchenne  Death by age 40Death by age 40  Dx: DNA, muscle biopsy decrease inDx: DNA, muscle biopsy decrease in dystrophindystrophin  CK:moderatly elevatedCK:moderatly elevated
  • 21. treatmenttreatment  No treatment prevent theNo treatment prevent the progressionprogression corticosteroid :controlled trial withcorticosteroid :controlled trial with predinsone 0,75mg/kg demonstratepredinsone 0,75mg/kg demonstrate moderate improvement in strengthmoderate improvement in strength &delay progression to wheel chair&&delay progression to wheel chair& respiratory compromiserespiratory compromise
  • 22. Emery-dreifussEmery-dreifuss  X linkedX linked  onset :childhoodonset :childhood  Triad of:Triad of: 1-early contracture elbow, ankle1-early contracture elbow, ankle &posterior cervical&posterior cervical 2-progressive scapulohumroperoneal2-progressive scapulohumroperoneal 3-cardiomyopathy with atrial conduction3-cardiomyopathy with atrial conduction defectdefect
  • 23.  CK :normal to or only moderateCK :normal to or only moderate elevatedelevated  The muscle biopsy :myopathicThe muscle biopsy :myopathic &fewer dystrophic&fewer dystrophic  DNA:mutation gene in Xq28 code forDNA:mutation gene in Xq28 code for protien emerinprotien emerin
  • 24. Limb girdle dystrophyLimb girdle dystrophy  AR majorityAR majority  Onset: adolescence or lateOnset: adolescence or late childhood: sever child recessive muscularchildhood: sever child recessive muscular dystrophydystrophy
  • 25.  AR: defect in sacroglycan component ofAR: defect in sacroglycan component of the DGC( sacroglycanopathythe DGC( sacroglycanopathy((  Alpha sacrglycan adhelin is account forAlpha sacrglycan adhelin is account for 20%20%  Onset:childhood& variableOnset:childhood& variable  No intellectual impairment or cardiacNo intellectual impairment or cardiac  Muscle biopsy :immune stain absent orMuscle biopsy :immune stain absent or diminished for sacroglycandiminished for sacroglycan
  • 26.  AD: onset: second and third decadesAD: onset: second and third decades  Protein defect:caveolin-3Protein defect:caveolin-3  There are multiple subtypesThere are multiple subtypes  AD type 1:1A,1B …AD type 1:1A,1B …  AR type 2:AR type 2:
  • 27. Congenital muscular dystrophyCongenital muscular dystrophy  ARAR Perinatal onsetPerinatal onset  c/p:hypotonia &proximalc/p:hypotonia &proximal weakness,arthrogryposisweakness,arthrogryposis  Two typesTwo types  CNS involvement: severCNS involvement: sever mental retardationmental retardation ,visual, seizure ..cerebrocular dysplasia,,visual, seizure ..cerebrocular dysplasia, progressive death by age 10-12progressive death by age 10-12  No CNS :classic typeNo CNS :classic type MRI (hypomyelination),MRI (hypomyelination), benign outcome, non progressivebenign outcome, non progressive  Muscle biopsy :dystrophy…Muscle biopsy :dystrophy…
  • 28. FSHFSH  InheritanceInheritance: AD: AD  Variable expression within the familiesVariable expression within the families  AgeAge: childhood or adult life: childhood or adult life  C/PC/P:: weakness early facial then descending to scapula stabilizerweakness early facial then descending to scapula stabilizer muscles &muscles of the upper limb& distal weaknessmuscles &muscles of the upper limb& distal weakness ..peroneal ,the rate of progression to forearm &pelvic girdle..peroneal ,the rate of progression to forearm &pelvic girdle  Asymmetrical/Asymmetrical/ deltoid preserved / joint contracture aredeltoid preserved / joint contracture are uncommonuncommon  Popeye handPopeye hand/ winging scapula// winging scapula/ no muscle hypertrophyno muscle hypertrophy  Early onset worse prognosisEarly onset worse prognosis  20% require wheelchair20% require wheelchair
  • 29. Work upWork up  CK:N or mild elevationCK:N or mild elevation  Muscles biopsy: myopathicMuscles biopsy: myopathic dystrophicdystrophic& occasionally prominent& occasionally prominent mononuclear infiltratemononuclear infiltrate  Gene: ch 4q35 gene deletionGene: ch 4q35 gene deletion
  • 30. Myotonic dystrophyMyotonic dystrophy  AD,AD, CTG repeatCTG repeat  Affect :Affect : skeletal,cardiac, smooth muscles, eye,endocrineskeletal,cardiac, smooth muscles, eye,endocrine &brain&brain  Onset :at any age ,usually at late 2Onset :at any age ,usually at late 2ndnd decadedecade  Some individual can be symptoms free theirSome individual can be symptoms free their entire lifeentire life  Sever form :congenital myotonic dystrophySever form :congenital myotonic dystrophy
  • 31.  C/P:weakness:C/P:weakness: (facial,temporalis wasting,ptosis,neck(facial,temporalis wasting,ptosis,neck flexor,distal weakness progress toflexor,distal weakness progress to involve limb girdle)involve limb girdle)  Weakness >myotoniaWeakness >myotonia  May be areflexicMay be areflexic
  • 32. systemicsystemic  Posterior sub scapular cataractPosterior sub scapular cataract  Testicular atrophy& impotenceTesticular atrophy& impotence  Intellectual impairmentIntellectual impairment  Hypersomnia (central & obstructive)Hypersomnia (central & obstructive)  Respiratory failureRespiratory failure  Elevation of serum glu, rarely frank DMElevation of serum glu, rarely frank DM  GI: dysphagea, pseudo obstructionGI: dysphagea, pseudo obstruction  Cardiac conduction defect sudden deathCardiac conduction defect sudden death  Fetal loss in femaleFetal loss in female
  • 33. PROMMPROMM  ADAD  Proximal weakness, no distalProximal weakness, no distal weaknessweakness  Myotonia &myalgiaMyotonia &myalgia  Less cardiac &other organLess cardiac &other organ involvement except cataractinvolvement except cataract
  • 34. Work upWork up  CK:N or mild elevationCK:N or mild elevation  EMG: myopathic &EMG: myopathic & myotoniamyotonia  Muscle biopsy: atrophic, non specificMuscle biopsy: atrophic, non specific  Gene :CTG repeat >50 in ch19q13.2Gene :CTG repeat >50 in ch19q13.2
  • 35. tttttt  Myotonia rarely sever to require tt:Myotonia rarely sever to require tt: phenytoin is the only safe drugphenytoin is the only safe drug  Annual ECG ..pacemaker mayAnnual ECG ..pacemaker may requiredrequired  Positive pressure ventilation supportPositive pressure ventilation support  High risk in surgery (cardiacHigh risk in surgery (cardiac &respiratory)&respiratory)  Sedation & opiod use with cautionSedation & opiod use with caution
  • 36. Distal dystrophyDistal dystrophy  TypesTypes  AD:4AD:4thth &6&6thth decadedecade  AR:in early adult onset/late secondAR:in early adult onset/late second or early 3or early 3rdrd  CK :elevated 200xN ARCK :elevated 200xN AR
  • 37. oculopharengealoculopharengeal  ADAD  Onset:5Onset:5thth &6&6thth decadedecade  Ptosis &dysphagea later all extra ocularPtosis &dysphagea later all extra ocular muscles &extremities affected (limb girdle)muscles &extremities affected (limb girdle) but distal can be significant in somebut distal can be significant in some variantvariant  Slow progressive ,death from aspirationSlow progressive ,death from aspiration pneumonia or starvationpneumonia or starvation  Ck:n or mild elevatedCk:n or mild elevated  Muscle biopsy :Muscle biopsy :rim vacuolesrim vacuoles  Genetic GCG repeat in ch14Genetic GCG repeat in ch14
  • 38.
  • 39. Congenital myopathyCongenital myopathy  Are distinguished from dystrophy inAre distinguished from dystrophy in threethree respect:respect:  Characteristic morphologic alterationCharacteristic morphologic alteration  At birthAt birth  Non progressiveNon progressive  However there are exception to allHowever there are exception to all these generalizationthese generalization  Inheritance: are variableInheritance: are variable
  • 40.  c/p:c/p: hypotonia with subsequent developmental delayhypotonia with subsequent developmental delay  Reduce muscles bulk, slender body build &long narrow faceReduce muscles bulk, slender body build &long narrow face  Skeletal abnormalities: high arched palate ,pectusSkeletal abnormalities: high arched palate ,pectus exacavitum, kyphscliosis, dislocated hip, pes cavusexacavitum, kyphscliosis, dislocated hip, pes cavus))  Absent or reduced muscle stretch reflexAbsent or reduced muscle stretch reflex  Weakness: limb girdle mostly, butWeakness: limb girdle mostly, but distaldistal weakness existweakness exist  CK &EMG may be normalCK &EMG may be normal  Muscle biopsy: the diagnostic methodMuscle biopsy: the diagnostic method
  • 41. Central core myopathyCentral core myopathy  Characterized by discrete zones ofCharacterized by discrete zones of myofibrillar disruption in the centermyofibrillar disruption in the center of muscles fiberof muscles fiber  AD but can be sporadicAD but can be sporadic  Mutation ch 19,similar to malignantMutation ch 19,similar to malignant hyperthermia patienthyperthermia patient  So anesthesia precaution areSo anesthesia precaution are necessarynecessary
  • 42. Nemaline myopathyNemaline myopathy  Pathology: thePathology: the presence of rods orpresence of rods or melamine bodies within muscles fibermelamine bodies within muscles fiber  AD or ARAD or AR  c/p:c/p:  Sever neonatalSever neonatal form which is fatal in theform which is fatal in the first year of lifefirst year of life  Mild staticMild static  Slowly progressiveSlowly progressive from birth or earlyfrom birth or early childhoodchildhood  Note :rods can present in HIV relatedNote :rods can present in HIV related myopathy ,some inflammatorymyopathy ,some inflammatory
  • 43. Centro nuclear (myotubularCentro nuclear (myotubular((  Pathology: large central nuclei in thePathology: large central nuclei in the muscle fibermuscle fiber  X linked/AD/ARX linked/AD/AR  sever neonatal/static or slowlysever neonatal/static or slowly progressiveprogressive  c/p: ptosis & opthalmoparesisc/p: ptosis & opthalmoparesis  Genetic defect: mutation inGenetic defect: mutation in myotubularin gene Xp28myotubularin gene Xp28
  • 45. Metabolic myopathyMetabolic myopathy  Glucose/glycogen metabolismGlucose/glycogen metabolism  Fattay acid metabolismFattay acid metabolism  Purine nucleotidePurine nucleotide  mitochondrialmitochondrial
  • 46. Metabolic myopathyMetabolic myopathy  Clues to hereditary metabolicClues to hereditary metabolic myopathymyopathy  Excersize induce weaknessExcersize induce weakness &myoglobinuria…glycogen &lipid&myoglobinuria…glycogen &lipid  Part of diffuse neurologicalPart of diffuse neurological syndrome…mitochondrialsyndrome…mitochondrial
  • 47. Glucose/glycogenGlucose/glycogen  Glucose &its storage is essential for theGlucose &its storage is essential for the short termshort term anaerobic energy (glycogensis)anaerobic energy (glycogensis)  Two clinical presentation:Two clinical presentation:  1-dynamic:type V/V11/V111/1X//XX11-dynamic:type V/V11/V111/1X//XX1  2-static:fix weakness2-static:fix weakness 1/111/1V1/111/1V  Inheritance:AR except forInheritance:AR except for phosphoglycerate kinasephosphoglycerate kinase
  • 48. Glycogensis with exerciseGlycogensis with exercise intoleranceintolerance  C/P: exercise intolerance in the childhoodC/P: exercise intolerance in the childhood followed by excertional induced muscle painfollowed by excertional induced muscle pain &myoglobinurea in sec or 3&myoglobinurea in sec or 3rdrd decade..decade..  (Second wind phenomena)(Second wind phenomena)  work up:work up: CK/EMG normal between the attack in early stageCK/EMG normal between the attack in early stage but after attack( myopathic &fibrillation)but after attack( myopathic &fibrillation)  Forearm exercise testForearm exercise test  Enzyme assayEnzyme assay  Muscle biopsyMuscle biopsy  Genetic for mutationGenetic for mutation
  • 49. What is 0ther causes ofWhat is 0ther causes of myoglobinureamyoglobinurea??
  • 50. Glycogensis with fixed weaknessGlycogensis with fixed weakness  Acid maltase deficiency:Acid maltase deficiency:  Enzyme convert glycogen to glucoseEnzyme convert glycogen to glucose  Three clinical variant:Three clinical variant:  Infantile: pompes: progressiveInfantile: pompes: progressive weakness ,enlargement of heart, tongueweakness ,enlargement of heart, tongue &liver&liver death by age 2death by age 2  Juvenile type: proximal weakness, mayJuvenile type: proximal weakness, may calf hypertrophy death by age 20 fromcalf hypertrophy death by age 20 from respiratory failurerespiratory failure  Adult type:2&7Adult type:2&7thth progressive limb girdle orprogressive limb girdle or scapuloperoneal .no liver ,no heartscapuloperoneal .no liver ,no heart involvementinvolvement
  • 51. Work upWork up  CK :moderately increasedCK :moderately increased  EMG: myopathic changes &EMG: myopathic changes &myotonicmyotonic discharge in paraspinusdischarge in paraspinus  Enzyme assay:Enzyme assay:  Muscle biopsy: a vacuolar myopathyMuscle biopsy: a vacuolar myopathy with high glycogen contentwith high glycogen content  Genetic: mutation in ch 17Genetic: mutation in ch 17
  • 52. Fatty acid metabolismFatty acid metabolism  Lipids are essential for aerobicLipids are essential for aerobic metabolismmetabolism  Dynamic & staticDynamic & static  CPT:carnitine palmitoyl transeferaseCPT:carnitine palmitoyl transeferase deficiencydeficiency  Carnitine deficiencyCarnitine deficiency
  • 53. CPTCPT  Type 1:infancy &child hood with hepaticType 1:infancy &child hood with hepatic dysfunctiondysfunction  Type 2:exertional myalgia &myoglobinurea,Type 2:exertional myalgia &myoglobinurea, it is the most frequently definableit is the most frequently definable metabolic defect presenting with myoglobinureametabolic defect presenting with myoglobinurea  AR ,gene 1p32AR ,gene 1p32  The attacks occur after prolonged exercise,The attacks occur after prolonged exercise, fasting, febrile illnessfasting, febrile illness  Unlike mecardle disease the patient can tolerateUnlike mecardle disease the patient can tolerate brief exercise ,no second wind phenomenabrief exercise ,no second wind phenomena  Muscle strength are normal at restMuscle strength are normal at rest
  • 54. lablab  CK:n at restCK:n at rest  Forearm exercise test :NForearm exercise test :N  EMG: n at rest ,&myopathic during theEMG: n at rest ,&myopathic during the attackattack  Muscle biopsy: usually N ,except ofMuscle biopsy: usually N ,except of myopathic changes after rhabdomylsismyopathic changes after rhabdomylsis  Enzyme assayEnzyme assay  ttt &meal frequency: increase CHO intakettt &meal frequency: increase CHO intake &education about fasting &exercise&education about fasting &exercise
  • 55. MitochondrialMitochondrial  Kearns-sayer:Kearns-sayer: opthalmoplegia, retinitis pigmentosa, heartopthalmoplegia, retinitis pigmentosa, heart block, hearing loss, short stature, ataxia, delayed 2block, hearing loss, short stature, ataxia, delayed 2ndnd sexualsexual characteristic, PN, respiratorycharacteristic, PN, respiratory  MERFMERF: myoclonic epilepsy, generalized seizure, ataxia,: myoclonic epilepsy, generalized seizure, ataxia, dementia, hearing loss, optic atrophy ,PN, cardiomyopathydementia, hearing loss, optic atrophy ,PN, cardiomyopathy &cutenous lipoma&cutenous lipoma  MNGLEMNGLE: mitochondrial neurogastrointestinal: mitochondrial neurogastrointestinal encephalomyopathyencephalomyopathy  POLIPPOLIP ::polyneuropathy,opthalmoplasia,leukoencephalopathy&polyneuropathy,opthalmoplasia,leukoencephalopathy& intestinal pseudo obstructionintestinal pseudo obstruction
  • 56. channelopathychannelopathy  Non dystrophic myotoniaNon dystrophic myotonia  Periodic paralysisPeriodic paralysis  It due to mutation in differentIt due to mutation in different channels gene leading to :channels gene leading to :  Hyper excitability :myotoniaHyper excitability :myotonia  In excitability: paralysisIn excitability: paralysis
  • 57. Chloride channelopathyChloride channelopathy  Mutation in CLMutation in CL channel..hyperexcitability afterchannel..hyperexcitability after depolarizationdepolarization  Myotonia congenita:Myotonia congenita:  AD..thomsen /AR:beckerAD..thomsen /AR:becker  C/P:C/P: muscle hypertrophy,muscle hypertrophy, myotonia/becker type has fluctuatingmyotonia/becker type has fluctuating limb girdle weaknesslimb girdle weakness
  • 58. Sodium channleopathySodium channleopathy  ADAD  Onset: first decadeOnset: first decade  Phenotypic types:Phenotypic types:  Paramyotonia congenitaParamyotonia congenita  Hyperkalemic periodic paralysisHyperkalemic periodic paralysis  myotonia :Potassium sensitive disorder :myotonia :Potassium sensitive disorder : myotonia fluctuantmyotonia fluctuant myotonia permanentmyotonia permanent acetazolamide responsive myotoniaacetazolamide responsive myotonia
  • 59. Calcium channelopathyCalcium channelopathy  HypokalemicHypokalemic  malignant hyperthermiamalignant hyperthermia
  • 60. C/P of channelopathyC/P of channelopathy
  • 61. Paramytonia congenitaParamytonia congenita  ADAD  Onset :1Onset :1stst decadedecade  Paradoxical myotonia (Aggravated byParadoxical myotonia (Aggravated by warm as well cold)warm as well cold)  Face ,neck,forearmFace ,neck,forearm  After several attempt of eye closure theAfter several attempt of eye closure the patient can not open the eyepatient can not open the eye  ttt: Na channels blocker mexiletinettt: Na channels blocker mexiletine
  • 62. Hyperkalamic periodic paralysisHyperkalamic periodic paralysis  K sensitive periodic paralysisK sensitive periodic paralysis  Onset :1Onset :1stst decadedecade  Attack last:1-2 hAttack last:1-2 h  During attack: areflexic with no ocular orDuring attack: areflexic with no ocular or respiratory muscles weaknessrespiratory muscles weakness  Strength is n between the attack, but someStrength is n between the attack, but some patient has interictal limb girdle weaknesspatient has interictal limb girdle weakness  Some families have myotonia &paramyotoniaSome families have myotonia &paramyotonia  Aggravated: fasting/cold, shortly after exercise, KAggravated: fasting/cold, shortly after exercise, K load, early AMload, early AM
  • 63.  Episodes are rarely serous enough toEpisodes are rarely serous enough to require acute tttrequire acute ttt  ttt:ttt:  oral CHOoral CHO  Prevention: thiazide,B agonist, lowPrevention: thiazide,B agonist, low K,high CHOK,high CHO  Avoid fasting, strenuous exercise/Avoid fasting, strenuous exercise/
  • 64. myotoniamyotonia  No weaknessNo weakness  Aggravated by K diet/ excretionAggravated by K diet/ excretion  Can response to acetazolamideCan response to acetazolamide
  • 65. hypokalemiahypokalemia  AD:AD:  It is the most frequent form of periodicIt is the most frequent form of periodic paralysisparalysis  Common in maleCommon in male  Age: adolescenceAge: adolescence  The attacks 3-24h/vague prodorme ofThe attacks 3-24h/vague prodorme of stiffness &heaviness& rarely ocular,stiffness &heaviness& rarely ocular, bulbar, respiratory involvedbulbar, respiratory involved  Early Myotonia of eyelid & late interictalEarly Myotonia of eyelid & late interictal proximal weaknessproximal weakness
  • 66.  AggravatedAggravated: CHO meal, cold,hrs post: CHO meal, cold,hrs post exercise, sleepexercise, sleep  Work up:K level q 30min /TFT/Work up:K level q 30min /TFT/  R/O 2R/O 2ndnd causes of hypokalemiacauses of hypokalemia  Tttt:Tttt:  Acute:Acute: oral K Q30min ,if symptoms severoral K Q30min ,if symptoms sever iv Kiv K  Prevention:Prevention:  Low CHO, low sodium dietLow CHO, low sodium diet ,spirnolactone, trimetrine,spirnolactone, trimetrine